Mizukami Y, Tajiri K, Nonomura A, Noguchi M, Taniya T, Koyasaki N, Nakamura S, Matsubara F
Pathology Section, Kanazawa University Hospital, Japan.
Anticancer Res. 1991 May-Jun;11(3):1333-8.
The effects of three hormonal agents with a different mechanism of action (tamoxifen [TAM], medroxyprogesterone acetate [MPA] and estradiol [E2]) on tumor growth, differentiation and oncogene expression were evaluated using the estrogen-receptor positive human breast carcinoma cell line MCF-7 transplanted into nude mice. In MCF-7 tumors treated with E2, tumor incidence, mean weight of tumors, 3H-thymidine labelling index, differentiation antigen HMFGM (human milk-fat globule membrane) and ras p21, c-myc, neu oncogene products, the level was significantly increased. On the other hand MPA suppressed all of them. TAM increased the level of c-myc expression and HMFGM antigen, but suppressed the others. This evidence indicates that E2 induces both proliferation and differentiation of MCF-7 tumor cells. MPA suppresses both proliferation and differentiation, and TAM induces differentiation and suppresses proliferation.
使用移植到裸鼠体内的雌激素受体阳性人乳腺癌细胞系MCF-7,评估了三种作用机制不同的激素制剂(他莫昔芬 [TAM]、醋酸甲羟孕酮 [MPA] 和雌二醇 [E2])对肿瘤生长、分化和癌基因表达的影响。在用E2治疗的MCF-7肿瘤中,肿瘤发生率、肿瘤平均重量、3H-胸腺嘧啶核苷标记指数、分化抗原HMFGM(人乳脂肪球膜)以及ras p21、c-myc、neu癌基因产物的水平均显著升高。另一方面,MPA抑制了所有这些指标。TAM增加了c-myc表达和HMFGM抗原的水平,但抑制了其他指标。这一证据表明,E2诱导MCF-7肿瘤细胞的增殖和分化。MPA抑制增殖和分化,而TAM诱导分化并抑制增殖。